Compare BLBD & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLBD | PAHC |
|---|---|---|
| Founded | 1927 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | N/A | 2014 |
| Metric | BLBD | PAHC |
|---|---|---|
| Price | $47.85 | $39.89 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 4 |
| Target Price | ★ $64.60 | $31.25 |
| AVG Volume (30 Days) | ★ 370.9K | 259.0K |
| Earning Date | 02-04-2026 | 02-04-2026 |
| Dividend Yield | N/A | ★ 1.22% |
| EPS Growth | 22.79 | ★ 288.74 |
| EPS | ★ 3.88 | 1.67 |
| Revenue | ★ $1,480,099,000.00 | $1,399,676,000.00 |
| Revenue This Year | $4.86 | $15.34 |
| Revenue Next Year | $3.41 | $3.28 |
| P/E Ratio | ★ $12.13 | $23.60 |
| Revenue Growth | 9.87 | ★ 33.72 |
| 52 Week Low | $30.04 | $16.16 |
| 52 Week High | $61.95 | $46.42 |
| Indicator | BLBD | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 39.98 | 53.10 |
| Support Level | $46.44 | $36.47 |
| Resistance Level | $47.89 | $40.43 |
| Average True Range (ATR) | 1.34 | 1.49 |
| MACD | -0.29 | 0.28 |
| Stochastic Oscillator | 25.33 | 68.90 |
Blue Bird Corp is an American bus manufacturing company. It is an independent designer and manufacturer of school buses. The company operates in two segments; the Bus segment which involves the design, engineering, manufacture, and sales of school buses and extended warranties; and the Parts segment which includes the sales of replacement bus parts. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada and Rest of the world.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.